Global Active Pharmaceutical Ingredients (API) Market Analysis, Size, Share, Growth, Future Trends, Covid-19 Impact, SWOT Analysis, Competition and Forecasts 2021 to 2028
Published Date: Dec 2021
No. of Pages: 150
Status: Published
Report Code: ARI101007
Global Active Pharmaceutical Ingredients (API) Market:
Global Size, Trends, Competitive, Historical & Forecast Analysis, 2021-2027- Rising prevalence of chronic diseases, increasing geriatric population and growing R&D in anti-viral drug are some of the major factors anticipated to drive the Growth the API Market.
Global Active Pharmaceutical Ingredients Market is valued at USD 184.2 Billion in 2020 and is expected to reach USD 284.4 Billion by 2027 with a CAGR of 6.4% over the forecast period.
Scope of Global Active Pharmaceutical Ingredients Market Report:
Active pharmaceutical ingredient (API) is the name utilized to mention to the biologically active component of a drug product that is capsule, tablet. Mostly, drug products are included with various components. Active pharmaceutical ingredient is one of the primary ingredients. These substances which make up a variable fraction of the drug product are essential to be biologically safe. The process for optimizing and composting the combination of components utilized in the drug is known as formulation. Active pharmaceutical ingredients are utilized for pharmacological activity in the diagnosis, treat, mitigation, treatment, or prevention of disease or to change the structure or function of the body.
There are two types of active pharmaceutical ingredients which are chemical synthetic drugs (usually produced by contract manufacturing outsourcing) and natural chemical drugs. The production of active pharmaceutical ingredients is exceptionally difficult. It includes a series of responses like blend to accomplish a specific change in the chemical design from short-sighted looking molecules. The high temperature and pressing factor control tasks of the reactions which are utilized in the formulations of these active pharmaceutical ingredients which include raw materials which are exceptionally flammable make it a cycle full of complexities and risks. The applications of API’s are lower risk of drug interaction, increased understanding of the drug and its action, increased compliance from the patient better acceptance of the drug’s side effects and symptoms.
COVID-19 pandemic has also impacted the global API Market. To relieve the indications and the different health conditions which a patient of COVID-19 appearances, like high fever, cough, and cold different sorts of medications are utilized thus the pharmaceutical business become the center of the globe during the pandemic. During COVID-19 pandemic, the economic and social burden has provoked government bodies to expand funding for vaccine advancement on a worldwide scale. This has prompted a rise in the development of the active pharmaceutical ingredients (API) market. However, the pharmaceuticals production and supply chain both got disturbed during lockdown. Due to the lockdowns conditions, slow production of APIs by the later resulted in less accessibility and higher costs for the materials required for generics invention.
The regions covered in global API Industry are North America, Europe, Asia-Pacific, Latin America and Rest of the World. On the basis of country level, the market of global active pharmaceutical ingredients is sub divided into U.S., Mexico, Canada, U.K., France, Germany, Italy, China, India, Japan, South East Asia, Middle East Asia (UAE, Egypt, Saudi Arabia) GCC, Africa, etc.
Rising Prevalence of Chronic Diseases, Increasing Geriatric Population and Growing R&D in Anti-Viral Drug are some of the Major Factors Driving the Market Growth
One of the major factors driving the growth of global API Industry is rising prevalence of chronic diseases. Rising number of chronic diseases such as diabetic, cardiovascular diseases, cancer and other is increasing the demand of drugs which leads to foster the growth of the global active pharmaceutical ingredients market. For example; as per the International Diabetes Federation, in 2019, 463 million individuals across the world were determined to have diabetes. In addition, the quantity of new cancer cases each year is relied upon to increment to 23.6 million by 2030. In addition, increasing geriatric population is also supplementing the market growth.
North America is expected to Dominate the Global Active Pharmaceutical Ingredients Market
North America is expected to dominate the global API Industry due to the increasing chronic diseases & other diseases, rising R&D activities and presence of key players in this region. For instance; according to the Centers for Disease Control and Prevention; around 795,000 individuals in the U.S. experience the ill effects of stroke each year, out of which 87% cases are of ischemic stroke. Rise in research and development programs in the drugs & medical science is also supplementing the market growth in this region. For example, in 2020, Pfizer signed a multi-year arrangement with Gilead Sciences to make and supply Gilead's antiviral medication (Remdesivir) for the treatment of COVID-19.
Asia Pacific is expected to witness the fastest growth in this market during the forecast period due to the increasing healthcare expenditure and large number of pharmaceutical companies. For instance; in December 2019, Dr Reddy's Laboratories dispatched Bortezomib for infusion in the US market, a conventional variant of Velcade of Millennium Pharmaceuticals. Bortezomib is utilized for the treatment of adult patients with various myeloma or with mantle cell lymphoma who have received somewhere around one earlier treatment.
Key Players:
Sun Pharmaceutical Industries Ltd.
Mylan NV
Pfizer Inc.
Sanofi SA
Novartis International AG
Teva Pharmaceutical Industries Ltd.
Merck & Co. Inc.
Eli Lilly and Company
AstraZeneca PLC
Bayer AG
Hoffmann-La Roche Ltd
Other
Global API Market Segmentation:
By Business Mode
Captive API
Merchant APIs
By Synthesis
Synthetic API
Biotech API
Other
By Drug Type
Generic
Branded
By Application
Pain Management
Respiratory Diseases
Orthopedic Disorder
Neurological Disorder
Diabetes
Other
By Region
North America - US, Mexico, Chile, Canada
Europe - UK, France, Germany, Italy
Asia Pacific - China, South Korea, Japan, India, Southeast Asia
Latin America - Brazil
Middle East and Africa - GCC, Africa, Rest of Middle East and Africa
TABLE OF CONTENTS
Chapter 1. Executive Summary
Chapter 2. Research Methodology
2.1. Research approach
2.2. Scope, definition, and assumptions
2.3. Data sources
2.3.1. Secondary Merchant API
2.3.1.1. Preliminary data mining
2.3.2. Primary Merchant API
2.3.2.1. Statistical Model
2.3.2.2. Data Triangulation
2.3.2.3. Research Objective
Chapter 3. Market Outlook
3.1. Introduction
3.2. Key trends
3.2.1. xx
3.3. Market drivers
3.3.1. Impact analysis of Market Drivers
3.4. Market restraints
3.4.1. Impact analysis of Market Restraints
3.5. Market opportunities
3.5.1. Impact analysis of Market Opportunities
3.6. Market Challenges
3.6.1. Impact analysis of Market Trends
3.7. Porter’s Five Forces’ analysis
3.7.1. Bargaining Power of Suppliers
3.7.2. Bargaining Power of Buyers
3.7.3. Threat of New Entrant
3.7.4. Threat of Substitutes
3.7.5. High Competitive Rivalry
3.8. Value chain analysis
Chapter 4. COVID-19 Impact On Active Pharmaceutical Ingredient (API) Market
Chapter 5. Global Active Pharmaceutical Ingredient (API) Market Overview, By Business Mode, 2015 - 2028(USD Million)
5.1. Global Active Pharmaceutical Ingredient (API) Market Share, By Business Mode, 2015 - 2028 (USD Million)
5.1.1. Captive API
5.1.1.1. Market Size and Projections,2015 - 2028 (USD Million)
5.1.1.2. Market Size and Projections, by Region, 2015 - 2028 (USD Million)
5.1.2. Merchant API
5.1.2.1. Market Size and Projections,2015 - 2028 (USD Million)
5.1.2.2. Market Size and Projections, by Region, 2015 - 2028 (USD Million)
Chapter 6. Global Active Pharmaceutical Ingredient (API) Market Overview, By Synthesis, 2015 - 2028(USD Million)
6.1. Global Active Pharmaceutical Ingredient (API) Market Share, By Synthesis, 2015 - 2028 (USD Million)
6.1.1. Synthetic API
6.1.1.1. Market Size and Projections,2015 - 2028 (USD Million)
6.1.1.2. Market Size and Projections, by Region, 2015 - 2028 (USD Million)
6.1.2. Biotech API
6.1.2.1. Market Size and Projections, 2015 - 2028 (USD Million)
6.1.2.2. Market Size and Projections, by Region, 2015 - 2028 (USD Million)
6.1.3. Other
6.1.3.1. Market Size and Projections, 2015 - 2028 (USD Million)
6.1.3.2. Market Size and Projections, by Region, 2015 - 2028 (USD Million)
Chapter 7. Global Active Pharmaceutical Ingredient (API) Market Overview, By Drug Type, 2015 - 2028(USD Million)
7.1. Global Active Pharmaceutical Ingredient (API) Market Share, By Drug Type, 2015 - 2028 (USD Million)
7.1.1. Generic
7.1.1.1. Market Size and Projections,2015 - 2028 (USD Million)
7.1.1.2. Market Size and Projections, by Region, 2015 - 2028 (USD Million)
7.1.2. Innovative
7.1.2.1. Market Size and Projections, 2015 - 2028 (USD Million)
7.1.2.2. Market Size and Projections, by Region, 2015 - 2028 (USD Million)
Chapter 8. Global Active Pharmaceutical Ingredient (API) Market Overview, By Application, 2015 - 2028(USD Million)
8.1. Global Active Pharmaceutical Ingredient (API) Market Share, By Application, 2015 - 2028 (USD Million)
8.1.1. Pain Management
8.1.1.1. Market Size and Projections,2015 - 2028 (USD Million)
8.1.1.2. Market Size and Projections, by Region, 2015 - 2028 (USD Million)
8.1.2. Respiratory Diseases
8.1.2.1. Market Size and Projections, 2015 - 2028 (USD Million)
8.1.2.2. Market Size and Projections, by Region, 2015 - 2028 (USD Million)
8.1.3. Orthopedic Disorder
8.1.3.1. Market Size and Projections, 2015 - 2028 (USD Million)
8.1.3.2. Market Size and Projections, by Region, 2015 - 2028 (USD Million)
8.1.4. Neurological Disorder
8.1.4.1. Market Size and Projections, 2015 - 2028 (USD Million)
8.1.4.2. Market Size and Projections, by Region, 2015 - 2028 (USD Million)
8.1.5. Diabetes
8.1.5.1. Market Size and Projections, 2015 - 2028 (USD Million)
8.1.5.2. Market Size and Projections, by Region, 2015 - 2028 (USD Million)
8.1.6. Other
8.1.6.1. Market Size and Projections, 2015 - 2028 (USD Million)
8.1.6.2. Market Size and Projections, by Region, 2015 - 2028 (USD Million)
Chapter 9. Global Active Pharmaceutical Ingredient (API) Market Overview, By Geography, 2015 - 2028(USD Million)
9.1. Global Active Pharmaceutical Ingredient (API) Market Share, By Geography, 2015 - 2028(USD Million)
9.1.1. Market Size and projections, by Countries, 2015 - 2028 (USD Million)
9.1.2. Market Share and CAGR Comparison, by Countries, 2020 - 2028 (%)
Chapter 10. North America Active Pharmaceutical Ingredient (API) Market Overview, By Countries, 2015 - 2028(USD Million)
10.1. North America Active Pharmaceutical Ingredient (API) Market Overview, 2015 - 2028 (USD Million)
10.1.1. Market Size and projections, 2015 - 2028 (USD Million)
10.1.2. North America Active Pharmaceutical Ingredient (API) Market Overview, By Business Mode, 2015 - 2028 (USD Million)
10.1.3. North America Active Pharmaceutical Ingredient (API) Market Overview, By Synthesis, 2015 - 2028 (USD Million)
10.1.4. North America Active Pharmaceutical Ingredient (API) Market Overview, By Drug Type,2015 - 2028 (USD Million)
10.1.5. North America Active Pharmaceutical Ingredient (API) Market Overview, By Drug Type,2015 - 2028 (USD Million)
10.1.6. North America Active Pharmaceutical Ingredient (API) Market Overview, By Countries, 2015 - 2028 (USD Million)
10.1.6.1. U.S. Active Pharmaceutical Ingredient (API) Market Overview, 2015 - 2028 (USD Million)
10.1.6.1.1. Market Size and projections, 2015 - 2028 (USD Million)
10.1.6.1.2. U.S. Active Pharmaceutical Ingredient (API) Market Overview, By Business Mode, 2015 - 2028 (USD Million)
10.1.6.1.3. U.S. Active Pharmaceutical Ingredient (API) Market Overview, By Synthesis, 2015 - 2028 (USD Million)
10.1.6.1.4. Other Segment
10.1.6.2. Canada Active Pharmaceutical Ingredient (API) Market Overview, 2015 - 2028 (USD Million)
10.1.6.2.1. Market Size and projections, 2015 - 2028 (USD Million)
10.1.6.2.2. Canada Active Pharmaceutical Ingredient (API) Market Overview, By Business Mode, 2015 - 2028 (USD Million)
10.1.6.2.3. Canada Active Pharmaceutical Ingredient (API) Market Overview, By Synthesis, 2015 - 2028 (USD Million)
10.1.6.2.4. Other Segment
10.1.6.3. Mexico Active Pharmaceutical Ingredient (API) Market Overview, 2015 - 2028 (USD Million)
10.1.6.3.1. Market Size and projections, 2015 - 2028 (USD Million)
10.1.6.3.2. Mexico Active Pharmaceutical Ingredient (API) Market Overview, By Business Mode, 2015 - 2028 (USD Million)
10.1.6.3.3. Mexico Active Pharmaceutical Ingredient (API) Market Overview, By Synthesis, 2015 - 2028 (USD Million)
10.1.6.3.4. Other Segment
Chapter 11. Europe Active Pharmaceutical Ingredient (API) Market Overview, By Countries, 2015 - 2028(USD Million)
11.1. Europe Active Pharmaceutical Ingredient (API) Market Overview, 2015 - 2028 (USD Million)
11.1.1. Market Size and projections, 2015 - 2028 (USD Million)
11.1.2. Europe Active Pharmaceutical Ingredient (API) Market Overview, By Business Mode, 2015 - 2028 (USD Million)
11.1.3. Europe Active Pharmaceutical Ingredient (API) Market Overview, By Synthesis, 2015 - 2028 (USD Million)
11.1.4. Europe Active Pharmaceutical Ingredient (API) Market Overview, By Drug Type,2015 - 2028 (USD Million)
11.1.5. Europe Active Pharmaceutical Ingredient (API) Market Overview, By Drug Type,2015 - 2028 (USD Million)
11.1.6. Europe Active Pharmaceutical Ingredient (API) Market Overview, By Countries, 2015 - 2028 (USD Million)
11.1.6.1. Germany
11.1.6.1.1. Market Size and projections, 2015 - 2028 (USD Million)
11.1.6.1.2. Germany Active Pharmaceutical Ingredient (API) Market Overview, By Business Mode, 2015 - 2028(USD Million)
11.1.6.1.3. Germany Active Pharmaceutical Ingredient (API) Market Overview, By Synthesis, 2015 - 2028(USD Million)
11.1.6.1.4. Other Segments
11.1.6.2. France
11.1.6.2.1. Market Size and projections, 2015 - 2028 (USD Million)
11.1.6.2.2. France Active Pharmaceutical Ingredient (API) Market Overview, By Business Mode, 2015 - 2028(USD Million)
11.1.6.2.3. France Active Pharmaceutical Ingredient (API) Market Overview, By Synthesis, 2015 - 2028(USD Million)
11.1.6.2.4. Other Segments
11.1.6.3. UK
11.1.6.3.1. Market Size and projections, 2015 - 2028 (USD Million)
11.1.6.3.2. UK Active Pharmaceutical Ingredient (API) Market Overview, By Business Mode, 2015 - 2028(USD Million)
11.1.6.3.3. UK Active Pharmaceutical Ingredient (API) Market Overview, By Synthesis, 2015 - 2028(USD Million)
11.1.6.3.4. Other Segments
11.1.6.4. Italy
11.1.6.4.1. Market Size and projections, 2015 - 2028 (USD Million)
11.1.6.4.2. Italy Active Pharmaceutical Ingredient (API) Market Overview, By Business Mode, 2015 - 2028(USD Million)
11.1.6.4.3. Italy Active Pharmaceutical Ingredient (API) Market Overview, By Synthesis2015 - 2028(USD Million)
11.1.6.4.4. Other Segments
11.1.6.5. Spain
11.1.6.5.1. Market Size and projections, 2015 - 2028 (USD Million)
11.1.6.5.2. Spain Active Pharmaceutical Ingredient (API) Market Overview, By Business Mode, 2015 - 2028(USD Million)
11.1.6.5.3. Spain Active Pharmaceutical Ingredient (API) Market Overview, By Synthesis, 2015 - 2028(USD Million)
11.1.6.5.4. Other Segments
11.1.6.6. Rest of Europe
11.1.6.6.1. Market Size and projections, 2015 – 2028
11.1.6.6.2. Rest of Europe Active Pharmaceutical Ingredient (API) Market Overview, By Business Mode, 2015 - 2028(USD Million)
11.1.6.6.3. Rest of Europe Active Pharmaceutical Ingredient (API) Market Overview, By Synthesis, 2015 - 2028(USD Million)
11.1.6.6.4. Other Segments
Chapter 12. Asia Pacific Active Pharmaceutical Ingredient (API) Market Overview, By Countries, 2015 - 2028 (USD Million)
12.1. Asia Pacific Active Pharmaceutical Ingredient (API) Market Overview, 2015 - 2028 (USD Million)
12.1.1. Market Size and projections, 2015 - 2028 (USD Million)
12.1.2. Asia Pacific Active Pharmaceutical Ingredient (API) Market Overview, By Business Mode, 2015 - 2028 (USD Million)
12.1.3. Asia Pacific Active Pharmaceutical Ingredient (API) Market Overview, By Synthesis, 2015 - 2028 (USD Million)
12.1.4. Asia Pacific Active Pharmaceutical Ingredient (API) Market Overview, By Drug Type,2015 - 2028 (USD Million)
12.1.5. Asia Pacific Active Pharmaceutical Ingredient (API) Market Overview, By Drug Type,2015 - 2028 (USD Million)
12.1.6. Asia Pacific Active Pharmaceutical Ingredient (API) Market Overview, By Countries, 2015 - 2028 (USD Million)
12.1.6.1. India
12.1.6.1.1. Market Size and projections, 2015 - 2028 (USD Million)
12.1.6.1.2. India Active Pharmaceutical Ingredient (API) Market Overview, By Business Mode, 2015 - 2028(USD Million)
12.1.6.1.3. India Active Pharmaceutical Ingredient (API) Market Overview, By Synthesis, 2015 - 2028 (USD Million)
12.1.6.1.4. Other Segments
12.1.6.2. China
12.1.6.2.1. Market Size and projections, 2015 - 2028(USD Million)
12.1.6.2.2. China Active Pharmaceutical Ingredient (API) Market Overview, By Business Mode, 2015 - 2028(USD Million)
12.1.6.2.3. China Active Pharmaceutical Ingredient (API) Market Overview, By Synthesis, 2015 - 2028 (USD Million)
12.1.6.2.4. Other Segments
12.1.6.3. Japan
12.1.6.3.1. Market Size and projections, 2015 - 2028 (USD Million)
12.1.6.3.2. Japan Active Pharmaceutical Ingredient (API) Market Overview, By Business Mode, 2015 - 2028(USD Million)
12.1.6.3.3. Japan Active Pharmaceutical Ingredient (API) Market Overview, By Synthesis, 2015 - 2028(USD Million)
12.1.6.3.4. Other Segments
12.1.6.4. South Korea
12.1.6.4.1. Market Size and projections, 2015 - 2028(USD Million)
12.1.6.4.2. South Korea Active Pharmaceutical Ingredient (API) Market Overview, By Business Mode, 2015 - 2028(USD Million)
12.1.6.4.3. South Korea Active Pharmaceutical Ingredient (API) Market Overview, By Synthesis, 2015 - 2028 (USD Million)
12.1.6.4.4. Other Segments
12.1.6.5. Rest of Asia Pacific
12.1.6.5.1. Market Size and projections, 2015 - 2028 (USD Million)
12.1.6.5.2. Rest of Asia Pacific Active Pharmaceutical Ingredient (API) Market Overview, By Business Mode, 2015 - 2028(USD Million)
12.1.6.5.3. Rest of Asia Pacific Active Pharmaceutical Ingredient (API) Market Overview, By Synthesis, 2015 - 2028 (USD Million)
12.1.6.5.4. Other Segments
Chapter 13. Middle East & Africa Active Pharmaceutical Ingredient (API) Market Overview, By Countries, 2015 - 2028 (USD Million)
13.1. Middle East & Africa Active Pharmaceutical Ingredient (API) Market Overview, 2015 - 2028 (USD Million)
13.1.1. Market Size and projections, 2015 - 2028 (USD Million)
13.1.2. Middle East & Africa Active Pharmaceutical Ingredient (API) Market Overview, By Business Mode, 2015 - 2028 (USD Million)
13.1.3. Middle East & Africa Active Pharmaceutical Ingredient (API) Market Overview, By Synthesis, 2015 - 2028 (USD Million)
13.1.4. Middle East & Africa Active Pharmaceutical Ingredient (API) Market Overview, By Drug Type,2015 - 2028 (USD Million)
13.1.5. Middle East & Africa Active Pharmaceutical Ingredient (API) Market Overview, By Drug Type,2015 - 2028 (USD Million)
13.1.6. Middle East & Africa Active Pharmaceutical Ingredient (API) Market Overview, By Countries, 2015 - 2028 (USD Million)
13.1.6.1. GCC
13.1.6.1.1. Market Size and projections, 2015 - 2028 (USD Million)
13.1.6.1.2. GCC Active Pharmaceutical Ingredient (API) Market Overview, By Business Mode, 2015 - 2028 (USD Million)
13.1.6.1.3. GCC Active Pharmaceutical Ingredient (API) Market Overview, By Synthesis, 2015 - 2028 (USD Million)
13.1.6.1.4. Other Segments
13.1.6.2. South Africa
13.1.6.2.1. Market Size and projections, 2015 - 2028 (USD Million)
13.1.6.2.2. South Africa Active Pharmaceutical Ingredient (API) Market Overview, By Business Mode, 2015 - 2028 (USD Million)
13.1.6.2.3. South Africa Active Pharmaceutical Ingredient (API) Market Overview, By Synthesis, 2015 - 2028 (USD Million)
13.1.6.2.4. Other Segments
13.1.6.3. Rest of Middle East & Africa
13.1.6.3.1. Market Size and projections, 2015 - 2028 (USD Million)
13.1.6.3.2. Rest of Middle East & Africa Active Pharmaceutical Ingredient (API) Market Overview, By Business Mode, 2015 - 2028 (USD Million)
13.1.6.3.3. Rest of Middle East & Africa Active Pharmaceutical Ingredient (API) Market Overview, By Synthesis, 2015 - 2028 (USD Million)
13.1.6.3.4. Other Segments
Chapter 14. South America Active Pharmaceutical Ingredient (API) Market Overview, By Countries, 2015 - 2028 (USD Million)
14.1. South America Active Pharmaceutical Ingredient (API) Market Overview, 2015 - 2028 (USD Million)
14.1.1. Market Size and projections, 2015 - 2028 (USD Million)
14.1.2. South America Active Pharmaceutical Ingredient (API) Market Overview, By Business Mode, 2015 - 2028 (USD Million)
14.1.3. South America Active Pharmaceutical Ingredient (API) Market Overview, By Synthesis, 2015 - 2028 (USD Million)
14.1.4. South America Active Pharmaceutical Ingredient (API) Market Overview, By Drug Type,2015 - 2028 (USD Million)
14.1.5. South America Active Pharmaceutical Ingredient (API) Market Overview, By Drug Type,2015 - 2028 (USD Million)
14.1.6. South America Active Pharmaceutical Ingredient (API) Market Overview, By Countries, 2015- 2026 (USD Million)
14.1.7. Brazil
14.1.7.1. Market Size and projections, 2015 - 2028 (USD Million)
14.1.7.2. Brazil Active Pharmaceutical Ingredient (API) Market Overview, By Business Mode, 2015 - 2028 (USD Million)
14.1.7.3. Brazil Active Pharmaceutical Ingredient (API) Market Overview, By Synthesis, 2015 - 2028 (USD Million)
14.1.7.4. Other Segments
14.1.8. Argentina
14.1.8.1. Market Size and projections, 2015 - 2028 (USD Million)
14.1.8.2. Argentina Active Pharmaceutical Ingredient (API) Market Overview, By Business Mode, 2015 - 2028 (USD Million)
14.1.8.3. Argentina Active Pharmaceutical Ingredient (API) Market Overview, By Synthesis, 2015 - 2028 (USD Million)
14.1.8.4. Other Segments
14.1.9. Rest of South America
14.1.9.1. Market Size and projections, 2015 – 2028
14.1.9.2. Rest of South America Active Pharmaceutical Ingredient (API) Market Overview, By Business Mode, 2015 - 2028 (USD Million)
14.1.9.3. Rest of South America Active Pharmaceutical Ingredient (API) Market Overview, By Synthesis, 2015 - 2028 (USD Million)
14.1.9.4. Other Segments
Chapter 15. Competitive Landscape
15.1. Competitive environment, 2021
15.2. Strategic framework
15.2.1. Partnership/agreement
15.2.2. Expansion
15.2.3. Mergers & Acquisitions
15.2.4. New Merchant API development
Chapter 16. Key Vendor Analysis
16.1. Sun Pharmaceutical Industries Ltd.
16.1.1. Company overview
16.1.2. Financial performance
16.1.3. Mice Benchmarking
16.1.4. Recent initiatives
16.1.5. SWOT analysis
16.2. Mylan NV
16.2.1. Company overview
16.2.2. Financial performance
16.2.3. Mice Benchmarking
16.2.4. Recent initiatives
16.2.5. SWOT analysis
16.3. Pfizer Inc.
16.3.1. Company overview
16.3.2. Financial performance
16.3.3. Mice Benchmarking
16.3.4. Recent initiatives
16.4. Sanofi SA
16.5. Novartis International AG
16.6. Teva Pharmaceutical Industries Ltd.
16.7. Merck & Co. Inc.
16.8. Eli Lilly and Company
16.9. AstraZeneca PLC
16.10. Bayer AG
16.11. Other
Chapter 17. Active Pharmaceutical Ingredient (API) Market Cost Analysis
17.1. Active Pharmaceutical Ingredient (API) Market Key Business Mode Analysis
17.1.1. Key Business Mode
17.1.2. Price Trend of Key Raw Material
17.1.3. Key Suppliers
17.1.4. Labor Cost
Chapter 18. Industrial Chain, Sourcing Strategy and Downstream Buyers
18.1. Active Pharmaceutical Ingredient (API) Market Industrial Chain Analysis
18.2. Upstream Business Mode Sourcing
18.3. Raw Material Sources of Active Pharmaceutical Ingredient (API) Market Major Manufacturers in 2021
18.4. Downstream Buyers
Chapter 19. Marketing Strategy Analysis, Distributors/Traders
19.1. Marketing Channel
19.1.1. Direct Marketing
19.1.2. Indirect Marketing
19.1.3. Marketing Channel Development Trend
19.2. Market Positioning
19.2.1. Pricing Strategy
19.2.2. Brand Strategy
19.2.3. Target Client
19.3. Distributors/Traders List
Chapter 20. Market Effect Factors Analysis
20.1. Merchant API Progress/Risk
20.1.1. Substitutes Threat
20.1.2. Merchant API Progress in Related Size
20.2. Consumer Needs/Customer Preference Change
20.3. Economic/Political Environmental Change
Chapter 21. Future Outlook of the Market
Disclaimer
List of Tables
1. Impact of Market drivers
2. Impact of Market restraints
3. Global Active Pharmaceutical Ingredient (API) Market, 2015-2028 (USD Million)
4. Hydrogen Generation requirement, by country, 2015-2028, (USD Million)
5. North America Active Pharmaceutical Ingredient (API) Market, By Business Mode, 2015-2028 (USD Million)
6. North America Active Pharmaceutical Ingredient (API) Market, By Synthesis, 2015-2028 (USD Million)
7. North America Active Pharmaceutical Ingredient (API) Market, By Drug Type, 2015-2028 (USD Million)
8. North America Active Pharmaceutical Ingredient (API) Market, By Application, 2015-2028 (USD Million)
9. Europe Active Pharmaceutical Ingredient (API) Market, By Business Mode, 2015-2028 (USD Million)
10. Europe Active Pharmaceutical Ingredient (API) Market, By Synthesis, 2015-2028 (USD Million)
11. Europe Active Pharmaceutical Ingredient (API) Market, By Drug Type, 2015-2028 (USD Million)
12. Europe Active Pharmaceutical Ingredient (API) Market, By Application, 2015-2028 (USD Million)
13. Asia Pacific Active Pharmaceutical Ingredient (API) Market, By Business Mode, 2015-2028 (USD Million)
14. Asia Pacific Active Pharmaceutical Ingredient (API) Market, By Synthesis, 2015-2028 (Merchant API, USD Million)
15. Asia Pacific Active Pharmaceutical Ingredient (API) Market, By Drug Type, 2015-2028 (Merchant API, USD Million)
16. Asia Pacific Active Pharmaceutical Ingredient (API) Market, By Application, 2015-2028 (Merchant API, USD Million)
17. Middle East & Africa Active Pharmaceutical Ingredient (API) Market, By Business Mode, 2015-2028 (USD Million)
18. Middle East & Africa Active Pharmaceutical Ingredient (API) Market, By Synthesis, 2015-2028 (USD Million)
19. Middle East & Africa Active Pharmaceutical Ingredient (API) Market, By Drug Type, 2015-2028 (USD Million)
20. Middle East & Africa Active Pharmaceutical Ingredient (API) Market, By Application, 2015-2028 (USD Million)
21. South America Active Pharmaceutical Ingredient (API) Market, By Business Mode, 2015-2028 (USD Million)
22. South America Active Pharmaceutical Ingredient (API) Market, By Synthesis, 2015-2028 (USD Million)
23. South America Active Pharmaceutical Ingredient (API) Market, By Drug Type, 2015-2028 (USD Million)
24. South America Active Pharmaceutical Ingredient (API) Market, By Application, 2015-2028 (USD Million)
25. Global Active Pharmaceutical Ingredient (API) Market, Company Market Share, 2020 - 2028 (%)
26. Sun Pharmaceutical Industries Ltd. : Business Mode Benchmarking
27. Sun Pharmaceutical Industries Ltd. : Financial Performance
28. Mylan NV : Business Mode Benchmarking
29. Mylan NV : Financial Performance
30. Pfizer Inc. : Business Mode Benchmarking
31. Pfizer Inc. : Financial Performance
32. Sanofi SA : Business Mode Benchmarking
33. Sanofi SA : Financial Performance
34. Novartis International AG : Business Mode Benchmarking
35. Novartis International AG : Financial Performance
36. Teva Pharmaceutical Industries Ltd. : Business Mode Benchmarking
37. Teva Pharmaceutical Industries Ltd.: Financial Performance
38. Merck & Co. Inc.: Business Mode Benchmarking
39. Merck & Co. Inc.: Financial Performance
40. Eli Lilly and Company: Business Mode Benchmarking
41. Eli Lilly and Company: Financial Performance
42. AstraZeneca PLC: Business Mode Benchmarking
43. AstraZeneca PLC: Financial Performance
44. Bayer AG: Business Mode Benchmarking
45. Bayer AG: Financial Performance
List of Figures
1. Market segmentation
2. Value chain analysis
3. Porter’s Five Forces’ analysis
4. Power of Suppliers
5. Power of Buyers
6. Threat of New Entrants
7. Threat of Substitute
8. Competitive Rivalry
9. Global Active Pharmaceutical Ingredient (API) Market share, By Business Mode, 2020 & 2028 (%)
10. Global Active Pharmaceutical Ingredient (API) Market share, by Captive API, By Business Mode, 2015 - 2028 (USD Million)
11. Global Active Pharmaceutical Ingredient (API) Market share, by Merchant API, By Business Mode, 2015 - 2028 (USD Million)
12. Global Active Pharmaceutical Ingredient (API) Market share, By Synthesis, 2020 & 2028 (%)
13. Global Active Pharmaceutical Ingredient (API) Market share, by Synthetic API, By Synthesis, 2015 - 2028 (USD Million)
14. Global Active Pharmaceutical Ingredient (API) Market share, by Biotech API, By Synthesis, 2015 - 2028 (USD Million)
15. Global Active Pharmaceutical Ingredient (API) Market share, by Other, By Synthesis, 2015 - 2028 (USD Million)
16. Global Active Pharmaceutical Ingredient (API) Market share, By Drug Type, 2020 & 2028 (%)
17. Global Active Pharmaceutical Ingredient (API) Market share, by Generic, By Drug Type, 2015 - 2028 (USD Million)
18. Global Active Pharmaceutical Ingredient (API) Market share, by Innovative, By Drug Type, 2015 - 2028 (USD Million)
19. Global Active Pharmaceutical Ingredient (API) Market Overview, By Application, 2020 - 2028 (%)
20. Global Active Pharmaceutical Ingredient (API) Market share, by Pain Management, By Application, 2015 - 2028 (USD Million)
21. Global Active Pharmaceutical Ingredient (API) Market share, by Respiratory Diseases, By Application, 2015 - 2028 (USD Million)
22. Global Active Pharmaceutical Ingredient (API) Market share, by Orthopedic Disorder, By Application, 2015 - 2028 (USD Million)
23. Global Active Pharmaceutical Ingredient (API) Market share, by Neurological Disorder, By Application, 2015 - 2028 (USD Million)
24. Global Active Pharmaceutical Ingredient (API) Market share, by Diabetes, By Application, 2015 - 2028 (USD Million)
25. Global Active Pharmaceutical Ingredient (API) Market share, by Other, By Application, 2015 - 2028 (USD Million)
26. Global Active Pharmaceutical Ingredient (API) Market share, by region, 2020 & 2028 (%)
27. Global Active Pharmaceutical Ingredient (API) Market share, by region, 2015 - 2028(USD Million)
28. North America Active Pharmaceutical Ingredient (API) Market, 2015 - 2028(USD Million)
29. North America Active Pharmaceutical Ingredient (API) Market share, by Countries, 2020 & 2028 (%)
30. U.S. Active Pharmaceutical Ingredient (API) Market, 2015 - 2028(USD Million)
31. Canada Active Pharmaceutical Ingredient (API) Market, 2015 - 2028(USD Million)
32. Mexico Active Pharmaceutical Ingredient (API) Market, 2015 - 2028(USD Million)
33. Europe Active Pharmaceutical Ingredient (API) Market, 2015 - 2028(USD Million)
34. Europe Active Pharmaceutical Ingredient (API) Market share, by Countries, 2020 & 2028 (%)
35. Spain Active Pharmaceutical Ingredient (API) Market, 2015 - 2028(USD Million)
36. UK Active Pharmaceutical Ingredient (API) Market, 2015 - 2028(USD Million)
37. Italy Active Pharmaceutical Ingredient (API) Market, 2015 - 2028(USD Million)
38. Germany Active Pharmaceutical Ingredient (API) Market, 2015 - 2028(USD Million)
39. France Active Pharmaceutical Ingredient (API) Market, 2015 - 2028(USD Million)
40. Rest of Europe Active Pharmaceutical Ingredient (API) Market, 2015 - 2028(USD Million)
41. Asia-Pacific Active Pharmaceutical Ingredient (API) Market, 2015 - 2028(USD Million)
42. Asia-Pacific Active Pharmaceutical Ingredient (API) Market share, by Countries, 2020 & 2028 (%)
43. China Active Pharmaceutical Ingredient (API) Market, 2015 - 2028(USD Million)
44. India Active Pharmaceutical Ingredient (API) Market, 2015 - 2028(USD Million)
45. Australia Active Pharmaceutical Ingredient (API) Market, 2015 - 2028(USD Million)
46. Japan Active Pharmaceutical Ingredient (API) Market, 2015 - 2028(USD Million)
47. Rest of Asia-Pacific Active Pharmaceutical Ingredient (API) Market, 2015 - 2028(USD Million)
48. Middle East & Africa Active Pharmaceutical Ingredient (API) Market, 2015 - 2028(USD Million)
49. Middle East & Africa Active Pharmaceutical Ingredient (API) Market share, by Countries, 2020 & 2028 (%)
50. GCC Active Pharmaceutical Ingredient (API) Market, 2015 - 2028(USD Million)
51. South Africa Active Pharmaceutical Ingredient (API) Market, 2015 - 2028(USD Million)
52. Rest Of Middle East & Africa Active Pharmaceutical Ingredient (API) Market, 2015 - 2028(USD Million)
53. South America Active Pharmaceutical Ingredient (API) Market, 2015 - 2028(USD Million)
54. Brazil Active Pharmaceutical Ingredient (API) Market, 2015 - 2028(USD Million)
55. Mexico Active Pharmaceutical Ingredient (API) Market, 2015 - 2028(USD Million)
56. Argentina Active Pharmaceutical Ingredient (API) Market, 2015 - 2028(USD Million)
57. Rest Of South America Active Pharmaceutical Ingredient (API) Market, 2015 - 2028(USD Million)
The Leading Key Players in Global Active Pharmaceutical Ingredients Api Market
